Epigenomics AG Validates DNA Methylation Test as Predictor of Disease Recurrence in Breast Cancer Patients
May 17, 2005 02:37 ET
|
Epigenomics AG
BERLIN, Germany, May 17, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), today revealed data confirming that its proprietary DNA methylation markers are closely correlated with...
Epigenomics AG Reports First Quarter 2005 Results
May 04, 2005 02:07 ET
|
Epigenomics AG
BERLIN, Germany, May 4, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard: ECX), today reported financial results for the first quarter ending March 31, 2005.
First Quarter...
Epigenomics AG to present at Lehman Brothers 8th Annual Global Healthcare Conference
March 29, 2005 02:15 ET
|
Epigenomics AG
BERLIN, Germany, March 29, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that Oliver...